HLA-C and neoplasm: We then utilized a similar B16F1 cell line expressing recombinant ZsGreen in frame with MHC class I and class II-restricted OVA peptides to assess FUS+MBs effects on innate immune cell numbers, DC expression of maturation markers, and DC tumor antigen uptake and presentation via flow cytometry.